Lion Point Capital’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12,000
| Closed | -$1.43M | – | 43 |
|
|
2022
Q2 | $1.43M | Hold |
12,000
| – | – | 0.16% | 26 |
|
|
2022
Q1 | $690K | Hold |
12,000
| – | – | 0.16% | 24 |
|
|
2021
Q4 | $1.43M | Hold |
12,000
| – | – | 0.38% | 22 |
|
|
2021
Q3 | $2.39M | Hold |
12,000
| – | – | 0.45% | 24 |
|
|
2021
Q2 | $2.09M | Hold |
12,000
| – | – | 0.36% | 25 |
|
|
2021
Q1 | $2.38M | Hold |
12,000
| – | – | 0.43% | 22 |
|
|
2020
Q4 | $2.36M | Hold |
12,000
| – | – | 0.45% | 18 |
|
|
2020
Q3 | $2.13M | Hold |
12,000
| – | – | 0.47% | 20 |
|
|
2020
Q2 | $2.78M | Buy |
+12,000
| New | +$2.78M | 0.67% | 20 |
|